1996
DOI: 10.1002/(sici)1096-8652(199612)53:4<242::aid-ajh6>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

Buffer may be the critical factor in measurement of anti-prothrombin antibody on a γ-ray-irradiated plate by enzyme-linked immunosorbent assay

Abstract: We investigated the influence of different buffers (Tris-buffer and phosphate buffered saline (PBS)/Tween-20 buffer) on anti-prothrombin antibody (aPT) measurement by enzyme linked irnmunosorbent assay (ELISA), employing a y-ray-irradiated plate. We found considerable discrepancies in aPT positivity between each buffer, and we suggest that the use of Tris-buffer is not suitable for aPT measurement with a y-ray-irradiated plate to measure aPT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
(9 reference statements)
0
1
0
Order By: Relevance
“…Furthermore, the buffer used after fixation of the target antigen to the plate can influence the result [68] and a better standardisation of the tests is mandatory [15,69]. Given a good standardisation it could be debated if these tests have to be repeated for confirmation of the diagnosis APLS because they are (theoretically) not influenced by non-pathogenic antibodies, cancer or drugs.…”
Section: Solid Phase Assays -The Big Hope For More Specific Diagnosticsmentioning
confidence: 99%
“…Furthermore, the buffer used after fixation of the target antigen to the plate can influence the result [68] and a better standardisation of the tests is mandatory [15,69]. Given a good standardisation it could be debated if these tests have to be repeated for confirmation of the diagnosis APLS because they are (theoretically) not influenced by non-pathogenic antibodies, cancer or drugs.…”
Section: Solid Phase Assays -The Big Hope For More Specific Diagnosticsmentioning
confidence: 99%